NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr | ₹1,231 Cr | ₹1,130 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹1,580 Cr |
Mar2022 | ₹1,383 Cr |
Mar2021 | ₹1,325 Cr |
Mar2020 | ₹1,231 Cr |
Mar2019 | ₹1,130 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1,580 Cr | 14.19 | |
Mar2022 | ₹1,383 Cr | 4.43 | |
Mar2021 | ₹1,325 Cr | 7.62 | |
Mar2020 | ₹1,231 Cr | 8.90 | |
Mar2019 | ₹1,130 Cr | - |
Compare Total Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹9,220.0 Cr | -4.5% | 11.6% | 248.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -4.5% |
11.6% |
248.9% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses